1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Mental Health Market Trends
  5. > CNS Drug News 05 OCTOBER 2015

CNS Drug News 05 OCTOBER 2015

  • October 2015
  • -
  • Espicom Business Intelligence
  • -
  • 24 pages

Industry Trend Analysis - Ocrelizumab Set To Fill Unmet Medical Need In PPMS
Industry Trend Analysis - Teva Stands To Win In Allergan/Impax Patent Battle
Industry Brief - CHMP Adopts Positive Opinion On Impax' Numient For PD
Industry Trend Analysis - Merck KGaA's Oral Cladribine Will Find Position In Crowded Market
Industry Brief - Biogen Licenses Worldwide Rights For Autoimmune Candidate From MTP
Industry Trend Analysis - Product Diversification Vital For ANI's Financial Security
Industry Brief - Betaconnect First Autoinjector For RRMS
Industry Brief - FDA Accepts Ontinua ER NDA Filing
Industry Brief - Copaxone Approved In Japan For Relapsing MS
Industry Brief - Medtronic Acquires Lazarus Effect
Industry Brief - Vanda Gets Favourable Ruling In Fanapt Suit
Industry Brief - FDA Accepts Vanda's Fanapt sNDA For Maintenance Treatment In Schizophrenia
Industry Brief - GW Reports Positive Top-Line Results From Cannabidiol Phase IIa Trial In Schizophrenia
Industry Trend Analysis - ITI-007's Advantage Over Competitors Will Secure Schizophrenia Market Share
Industry Trend Analysis - Europe Offers New Revenue Streams For Intuniv
Industry Brief - FDA Approves Vraylar For Bipolar I Disorder And Schizophrenia
Industry Trend Analysis - Patent Affirmation A Boon For Shire's Development
Industry Brief - Allergan, Mylan Launch Paliperidone Tablets
Industry Brief - Depomed Files Patent Infringement Suit Against Actavis Over Generic Nucynta ER
Industry Brief - First Patient Dosed In XaraColl MATRIX-2 Phase III Study
Industry Brief - Xenon Achieves Milestone In Pain Discovery Collaboration With Genentech
Industry Brief - Heron's HTX-011 Phase II Study In Postoperative Pain Meets Endpoints
Industry Trend Analysis - Zalviso's EMA Approval Is A Vital First Step For AcelRx
Industry Brief - Depomed Receives Favourable Decision Against Endo Pharmaceuticals Over Opana ER Patent
Industry Brief - CHMP Issues Positive Opinion On Ionsys In Postoperative Pain
Industry Trend Analysis - Astellas/Chromocell Agreement Increases Pipeline Diversity
Industry Brief - Jubilant Gains Zolmitriptan Approval
Industry Trend Analysis - Regeneron/MTP Collaboration In Asia Will Lead To Further Development
Industry Brief - FDA Approves Abuse-Deterrent MorphaBond ER
Industry Brief - FDA Accepts Probuphine NDA For Review
Industry Trend Analysis - Contrave Will Place Orexigen Back On Track
Industry Brief - Contrave NDA Submitted In South Korea
Industry Brief - FDA Accepts Sustol NDA For Review
Industry Brief - FDA Grant Alcobra's MDX Fast Track Designation For Fragile X Syndrome
Industry Brief - Alector Raises Funds To Advance Neurodegenerative Pipeline
Industry Brief - Strides To Acquire CNS Divisions Of Erstwhile Ranbaxy
Industry Brief - BioMotiv/Biogen Enter Neuroscience Collaboration
Industry Trend Analysis - Pharma Industry Will Need To Heed FTC's 'Product Hopping' Warning

Table Of Contents

CNS Drug News 05 OCTOBER 2015

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

  • $ 10995
  • Industry report
  • September 2016
  • by Global Data

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024 Summary Attention deficit hyperactivity disorder (ADHD) is characterized by excessive levels ...

Substance Abuse Treatment Market: By Addiction Substances (Alcohol, Drugs, Cigarettes and Coffee); By Category (Alcohol, Nicotine Dependence Therapeutics, Drug Abuse Therapeutics) & By Region -Forecast (2016-2021)

Substance Abuse Treatment Market: By Addiction Substances (Alcohol, Drugs, Cigarettes and Coffee); By Category (Alcohol, Nicotine Dependence Therapeutics, Drug Abuse Therapeutics) & By Region -Forecast (2016-2021)

  • $ 5250
  • Industry report
  • September 2016
  • by Industry ARC

Alcoholism and drug dependence and addiction, known as substance use disorders and rehabilitation treatments are classified as substance abuse treatment. Some of the common symptoms of drug abuse are ...

Psychotherapeutic Drugs Market: By Type (Antipsychotics, Antidepressants, Antimaniacs, and Anxiety Drugs) & By Geography -Forecast (2016-2021)

Psychotherapeutic Drugs Market: By Type (Antipsychotics, Antidepressants, Antimaniacs, and Anxiety Drugs) & By Geography -Forecast (2016-2021)

  • $ 5250
  • Industry report
  • August 2016
  • by Industry ARC

Psychotherapeutic drugs are used to treat mental illnesses such as extreme mood swings, social withdrawal, long lasting depression, confused thinking, and suicidal thought. schizophrenia, bipolar disorder, ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.